AzTrials
AzTrials

Optic Nerve Sheath DiameterNCT04339244

Effect of Pressure Regulation on Optic Nerve Sheath Diameter

A study testing RALRP under lower mean BP in people with Optic Nerve Sheath Diameter, run by Keimyung University Dongsan Medical Center at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Intracranial pressure is known to increase during robot-assisted laparoscopic radical prostatectomy (RALRP) due to steep trendelenberg position. Measurement of optic nerve sheath diameter (ONSD) is a indirect method which can assess the degree of intracranial pressure. Read more about this study

Who is it for?
Ages 30 to 80 years
Conditions the study is for
Optic Nerve Sheath Diameter
What is being tested?
RALRP under lower mean BP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteSouth Korea
Study dates
1 Apr 2020to 15 Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Prostate cancer receiving RALRP

Who cannot join

  • glaucoma
  • intracranial tumor
  • previous disease elevating intracranial pressure

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Hong ji HEE

    Daegu, 42601

Other trials in South Korea

About this study

Official title: Effect of Arterial Pressure Regulation on Optic Nerve Sheath Diameter During Robot Assisted Laparoscopic Surgery

Intracranial pressure is known to increase during robot-assisted laparoscopic radical prostatectomy (RALRP) due to steep trendelenberg position. Measurement of optic nerve sheath diameter (ONSD) is a indirect method which can assess the degree of intracranial pressure.

This study is designed to measure the ONSD during RALRP under regulation of arterial pressure.

Read the detailed description

During last decades, RALRP has been advocated due to the advantages of short hospital stay, reduced blood loss during surgery, less postoperative pain and complication. During RALRP, steep trendelenberg postion and pneumoperitoneum are required essentially, and this is for the acquisition of adequite surgical field. However, such position and pneumoperitoneum can result in harmful hemodynamic change. Previous study demonstrated that patients of RALRP showed 12.5% increase of ONSD.

The relationship of ONSD and increase of intracranial pressure has been proved previously through many studies. Recent meta analysis showed that ONSD measurement for the monitor of ICP demonstrated that sensitivity 0.9, specificity 0.85 and ROC cuve 0.983.

In addition, increase of ONSD during RALRP can be affected by the degree of arterial pressure and end tidal CO2 increase.

This study is designed to see the effect of arterial pressure regulation on the increase of ONSD

Being tested
RALRP under lower mean BP
Keywords
arterial pressure regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RALRP under lower mean BPOther

    RALRP under regulation of lower mean BP

  • RALRP under lower mean BPOther

    RALRP under regulation of highly normal mean BP

Study groups in NCT04339244
Study groupRoleWhat they receive
ONSD measurement under lower blood pressureActive comparatorONSD measurement under mean blood pressure of 60~70 mmHg
Receives: Other: RALRP under lower mean BP
ONSD measurement under highly normal blood pressureActive comparatorONSD measurement under mean blood pressure of 90~100 mmHg
Receives: Other: RALRP under lower mean BP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. optic nerve sheath diameter change among 4 time period

    optice nerve sheath diameter change among 4 time period

    Measured: Baseline, 1 hour, 2 hours, 2.5 hours after completion of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2020
  2. Study start1 Apr 2020
  3. Primary completion15 Aug 2020
  4. Study completion15 Sep 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04339244
Sponsor's protocol ID
2019-07-049
Status last verified
Oct 2020
First submitted
6 Apr 2020
Last updated
14 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing RALRP under lower mean BP in people with Optic Nerve Sheath Diameter, run by Keimyung University Dongsan Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

optic nerve sheath diameter change among 4 time period (time frame: Baseline, 1 hour, 2 hours, 2.5 hours after completion of the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in